Neuralink将人类试验扩大到21人,其大脑植入使思想控制装置达到最多40个工作小时。 Neuralink expands human trials to 21 people, with its brain implant enabling thought-controlled devices at up to 40 wpm.

Neuralink已将其人类试验扩大到全球21名参与者,比9月的12人有所增加,没有关于与装置有关的严重不利事件的报告。 Neuralink has expanded its human trials to 21 participants globally, up from 12 in September, with no serious device-related adverse events reported. N1型植入装置有多达1 000个灵活电极,使瘫痪者能够控制计算机、移动装置和运用思维的机器人武器,每分钟打字最多40个字。 The N1 implant, featuring up to 1,000 flexible electrodes, enables paralyzed individuals to control computers, mobile devices, and robotic arms using thought, achieving up to 40 words per minute typing. 美国,英国和加拿大正在进行试验,计划在2026年推出下一代植入物,其能力将提高三倍. Trials are underway in the U.S., UK, and Canada, with plans for a next-generation implant—three times more capable—expected in 2026. 今后的目标包括恢复言论和远见,尽管长期的安全和道德问题依然存在。 Future goals include restoring speech and vision, though long-term safety and ethical concerns remain.